Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for September 2009
September 1, 2009
- 'Project Runway' Designer Launches New Online Video Series to Educate About Living with HIV and AIDS and Help Combat HIV Stigma
- Daiichi Sankyo and Ranbaxy Leverage New Business Model with Launch of Evista in Romania
- Neurobiological Technologies Announces Board Approval of Plan of Liquidation and Dissolution
September 2, 2009
- BioDelivery Sciences to Consolidate Newark Operations and Bioral Amphotericin B Development at Raleigh Headquarters
- Bristol-Myers Squibb Completes Acquisition of Medarex, Inc.
- FDA Advisory Committee Recommends Randomized Trial to Support Proposed Indication for Clolar in Adult AML
- Danaher to Acquire Life Sciences Instrumentation Businesses From MDS Inc. and Life Technologies Corporation
- Pfizer Concludes Previously Disclosed Settlement Agreement With U.S. Department Of Justice Regarding Past Promotional Practices
September 3, 2009
- Dainippon Sumitomo Pharma to Acquire Sepracor for U.S. $23.00 Per Share in an All-Cash Tender Offer Valued at Approximately U.S. $2.6 Billion
- Akela Pharma announces restructuring
- Algeta Signs $800 Million (EUR560m) Global Agreement With Bayer for Development and Commercialization of Alpharadin for Bone Metastases
- BioMS Medical Provides Update on Dirucotide
- Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive
- Delcath Establishes Queensbury, NY Operations Facility
- FDA Study Indicates Most Industry Postmarketing Studies Meet Timelines
- Pfizer, Wyeth and Johnson & Johnson to Present at PharmaMed Marketing & Media Conference
- Three Directors Set For Newly-Combined Merck
- Metabasis Hires Financial Advisor to Evaluate Strategic Alternatives
- Blue Spoon Consulting Updates Briefing Note: ?Pharmaceutical Promotion At Its Productivity Frontier'
September 4, 2009
- Elan Issues Statement Regarding Federal Court Ruling on Tysabri Collaboration Agreement
- Carey & Danis LLC Announces Four Lawsuits Against the Makers of Levaquin
- Tim Gunn Hosts Addressing Psoriasis Fashion Show to Raise Awareness of Psoriasis
- Biogen Idec Announces Proposal to Acquire All Outstanding Shares of Facet for $14.50 per Share in Cash
September 8, 2009
- Supply Plan of "Tamiflu" Anti-influenza Drug
- Sanofi Pasteur and Butantan Institute to Provide A(H1N1) Vaccine to Brazilian Government
- Shire News: Update on velaglucerase alfa
- Roche Announces New Corporate Executive Committee
- Facet Biotech's Board of Directors Rejects Biogen Idec's Unsolicited Proposal as Inadequate
- SEC Charges Seattle-Area Biotech Company With Fraudulently Hyping Stem Cell Breakthrough
September 9, 2009
- Mylan Parts Ways with Chief Financial Officer Jolene Varney
- AIR Health Group Launches, First Analytic Marketing Tool Debuts In Pharma Industry
- Large Majorities of Public Blame Health Insurers, Drug Industry, Republicans and Business for Problems with Our Current Health Care System
September 10, 2009
- Dynavax Reports FDA Removes Clinical Hold on HEPLISAV Phase 3 Hepatitis B Vaccine
- Merck Updates Status of Clinical Development Programs for Investigational CGRP Receptor Antagonist Treatments for Acute Migraine; MK-3207 Clinical Development Discontinued
- Marketing Exclusivity for First-in-Class Drugs Has Shortened to 2.5 Years
September 11, 2009
- Alkermes Chairman Richard Pops to Resume Role of CEO
- Mistrial Declared in First Federal Fosamax Trial
- One-stop SEO Service Provider Delivers New Options to Strengthen Online Businesses
- HPV Vaccine Study Shows Why Few Women Getting Shots
- Roger Green and Associates (RG+A) announce DPS Tracker
- Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued
September 14, 2009
- Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG
- Lilly Names New Business Leaders
- Lilly Unveils Blueprint for Speeding Innovative Medicines to Patients
September 15, 2009
- Dr. Marijn E. Dekkers to be new CEO of Bayer from October 1, 2010
- Elan Cures Breach of Tysabri Collaboration Agreement and Amends Terms of Transaction with Johnson & Johnson
- 78 percent of Americans see pharmaceutical industry deals as harmful
- BioCryst Announces Partnerships for Peramivir for Influenza Outside the U.S.
- Chicago Interactive Agency Marcel Media Wins HealthLeaders Media Marketing Award
- Appeals Court Affirms Patent Infringement Rulings Against Roche's peg-EPO Product
September 16, 2009
- Bristol-Myers Squibb Company Announces Sale to Taisho Pharmaceutical Co Ltd., of Its OTC Assets in Asia Pacific (Excl. China & Japan) and Shares in PT Bristol-Myers Squibb Indonesia Tbk
- Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average Physician
September 17, 2009
- FDA Sends Warning Letters to Allergan and Bioniche
- FDA Requires Boxed Warning for Promethazine Hydrochloride Injection
- Wellcome Trust and Merck Launch First of Its Kind Joint Venture to Develop Affordable Vaccines for Low-Income Countries
- Renovo - End of Offer Period & Restructuring
- Johnson & Johnson and Elan Corporation plc Announce Closing of Transaction Related to Alzheimer's Immunotherapy Program and Equity Investment
- FDA Sends Warning Letter to Bioniche Pharma Over Sotradecol Web Pages
September 18, 2009
- Pharmapalooza 2 Keeps the Beat Going Strong for Children's Health
- ZymoGenetics Appoints Dennis M. Miller, Ph.D., Senior Vice President, Research and Preclinical Development
- New Appointments at London Genetics to Drive Strategy Forward
- Rite Aid Names Ernie Richardsen Group Vice President, Pharmaceutical Purchasing and Clinical Services
September 21, 2009
- King Announces Commercial Availability of EMBEDA
- AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Constipation
- Maxygen Announces Consummation of Joint Venture Transaction With Astellas
- Biogen Idec Commences Tender Offer for Facet Biotech
September 22, 2009
- David Bearss Resigns as Chief Scientific Officer to Join Huntsman Cancer Institute as Co-director of Center for Investigational Therapeutics
- IMS Appoints Don Otterbein General Manager, Business Transformation Services, to Lead Expanded Knowledge Process Outsourcing Initiative
- Adolor Acquires Rights to Clinical-Stage Product Candidate from Eli Lilly and Company
- MedWatch - Natalizumab (marketed as Tysabri) - FDA continues to receive reports of progressive multifocal leukoencephalopathy (PML)
- Watson Names G. Frederick Wilkinson Executive Vice President, Global Brands
- Appointment of Claude Bertrand as Executive Vice President, Chief Scientific Officer of Ipsen
- Lilly Announces New U.S. Affiliate Leader
- Health Industry Lobbyists Hosted at Least 130 Fundraisers for Members of Congressional Health Committees This Year
- GSW Worldwide Announces New Members
- ScienceFirst Staff Expansion
- Mink Named President & CEO of ANGUS Chemical Company
- Baer Consulting launches new division
- Burnham Appoints Michael R. Jackson, Ph.D., Vice President for Drug Discovery & Development
September 23, 2009
- CombinatoRx Stock Trading Halted Today; FDA Advisory Committees Meet to Discuss Exalgo
- Janssen-Cilag's Stelara (Black Triangle Drug) (ustekinumab) Approved by NICE for the Treatment of Moderate to Severe Plaque Psoriasis
- LEO Pharma Repurchases Product Rights From Warner Chilcott
- Merck and QIAGEN Collaborate to Accelerate Access to Cervical Cancer Vaccination and Screening in Developing Countries
- AB Research adds CRO veteran Daniel Menard to its management team as Canadian and Hungarian sites's activity climb to historical highs
- Former FDA Commissioner Joins CHT
- Semafore Retains Management Consulting Firm; Names Principal to Key Management Position
- Aegis Adds Vice President of Sales
- Merrimack Pharmaceuticals Names Clet Niyikiza, Ph.D. Senior Vice President, Development
- Michael Howe, Former CEO MinuteClinic, Joins MEDNETWorld Board of Directors
- IGI Labs, Inc. Announces Narendra N. Borkar's Appointment to Its Board of Directors
- U.S. District Court Upholds Validity of Lilly's Evista Patents Through 2014
- ScienceFirst Staff Expansion
September 24, 2009
- Sepracor Announces Expiration of Hart-Scott-Rodino Waiting Period
- Teva Provides Update on Generic Evista Litigation
- OctoPlus N.V. (NL) - OctoPlus announces further efficiency measures
September 25, 2009
- Pfizer and Eisai Continue Aricept Collaboration
- Tamiflu (oseltamivir) for Oral Suspension: Medication Dosing Errors Reported
- Eisai Announces Agreement with Pfizer on Strategic Alliance for Alzheimer's Disease Treatment Aricep
- Frances D. Fergusson And John P. Mascotte Elected To Pfizer's Board Of Directors
- Sitagliptin (marketed as Januvia and Janumet): Cases of acute pancreatitis reported
- Heart Rhthym Society Taps Publicis Consultants
- Merck Statement About JANUVIA (sitagliptin) and JANUMET (sitagliptin/metformin)
September 26, 2009
September 27, 2009
September 28, 2009
- Abbott to Acquire Solvay Pharmaceuticals Business
- Johnson & Johnson and Crucell Announce Strategic Collaboration to Develop Innovative Products, Including Therapies for Influenza Prevention and Treatment
